IL10 and neoplasm: It is becoming clear that IL-10 serves as a non-redundant suppressive mechanism of MDSCs, and accordingly, blockade of IL-10 signaling or neutralization of IL-10 leads to alleviated T-cell suppression, delayed tumor progression, and improved therapeutic efficacy (37, 42).